Company / Operating Cash Flow
Lunai Bioworks Inc. Operating Cash Flow History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$1.5M
FY2017
5-year range
-$2.1M / -$24.9K
FY2013-FY2017
Trend
+27.6%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$2M to -$1M over the past 3 years.
Based on SEC 10-K filings.
-$1M in FY2017.
Improved from -$2M to -$1M over the past 3 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, operating cash flow increased 27.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$1.5M | +27.6% |
| FY2016 | -$2.0M | +4.5% |
| FY2014 | -$2.1M | -8441.3% |
| FY2011 | -$24.9K | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026